骨肉瘤
基因敲除
顺铂
癌症研究
调节器
长非编码RNA
癌变
转录因子
体内
细胞生长
生物
小RNA
细胞生物学
下调和上调
化疗
化学
癌症
细胞培养
基因
遗传学
作者
Yibin Meng,Dingjun Hao,Yunfei Huang,Shuaijun Jia,Jianan Zhang,Xirui He,Liang Sun,Deyin Liu
标识
DOI:10.1016/j.bbrc.2019.10.180
摘要
Long noncoding RNAs (lncRNAs) have been identified to be critical regulator in the osteosarcoma (OS) tumorigenesis. However, the role of lncRNA MIR17HG in the OS proliferation and chemotherapy resistance is still unclear. Here, this research aims to investigate the function of lncRNA MIR17HG in the OS proliferation and cisplatin resistance. Clinically, results revealed that higher MIR17HG expression was associated with shorter overall survival. Functional investigations indicated that MIR17HG promoted the proliferation, invasion and cisplatin resistance of OS cells in vitro, and the MIR17HG knockdown inhibited the growth in vivo. Mechanistically, MIR17HG targeted the miR-130a-3p/SP1 axis, moreover, transcription factor SP1 bind with the MIR17HG promoter region to promote its expression. Taken together, MIR17HG displays the tumor-promotive role in the progression of OS through SP1/MIR17HG/miR-130a-3p/SP1 feedback loop. Our findings might help us to offer novel therapeutic strategies for OS.
科研通智能强力驱动
Strongly Powered by AbleSci AI